Shantell M. Kirkendoll
A Michigan Medicine researcher outlines the relationship between obesity, nonalcoholic steatohepatitis cirrhosis and a rising liver transplant burden.
Obesity is driving the rise of nonalcoholic steatohepatitis cirrhosis (NASH), the end of the fatty liver disease spectrum that begins with accumulation of fat in the liver, followed by ballooning, scarring, cirrhosis and eventually liver failure and cancer.
There are no drugs to treat fatty liver disease, which is quickly becoming a leading cause of liver transplants.
Neehar Parikh, M.D., M.S., a liver specialist and clinical lecturer at Michigan Medicine, is examining the pace at which America’s obesity rate is putting pressure on the transplant community.
Read more: http://labblog.uofmhealth.org/rounds/nash-may-overtake-hepatitis-c-as-top-liver-transplant-cause
No comments:
Post a Comment